Physician profile
Daniel Ruiz
NPI 1467958355
$554.03
in general payments reported to CMS, 2019-2025
9 companies · $554 in 2025
The $554 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $127.20 | 2025 | Extended Holter |
| Heartflow, INC. | $106.65 | 2025 | |
| Edwards Lifesciences Corporation | $96.39 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $92.17 | 2025 | Onyx Frontier, Symplicity G3 |
| Pfizer INC. | $50.87 | 2025 | |
| Cardiva Medical, INC. | $27.72 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Atricure, INC. | $19.87 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Cvrx, INC. | $17.72 | 2025 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $15.44 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ruiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.